Fair Value Measurements and Financial Instruments (Tables)

12 Months Ended

Jan. 29, 2022

Fair Value of Assets and Liabilities Measured on a Recurring Basis

The following table presents our assets and liabilities measured at fair value on a recurring basis, which utilize Level 2 inputs:


	January 29, 2022		January 30, 2021
Assets:
Foreign currency contracts (1)	$	3.8		$	2.5
Company-owned life insurance(2)	0.6			2.7
Total assets	$	4.4		$	5.2
Liabilities:
Foreign currency contracts (3)	$	0.4		$	2.4
Nonqualified deferred compensation(3)	0.6			0.6
Total liabilities	$	1.0		$	3.0

___________________

(1) Recognized in prepaid expenses and other current assets on our Consolidated Balance Sheets.

(2) Recognized in other non-current assets on our Consolidated Balance Sheets.

(3) Recognized in accrued liabilities and other current liabilities on our Consolidated Balance Sheets.

Gains and Losses on Derivative Instruments and Foreign Currency Transaction

The following table presents activity related to the trading of derivative instruments and the offsetting impact of related balances denominated in foreign currencies recognized in SG&A expenses in our Consolidated Statements of Operations:


	Fiscal Year
	2021		2020		2019
Gains (losses) on the changes in fair value of derivative instruments	$	9.6	$	(6.1)	$	4.1
(Losses) gains on the re-measurement of related intercompany loans and third-party accounts payable denominated in foreign currencies	(13.0)		5.1		(3.1)
Net (losses) gains	$	(3.4)	$	(1.0)	$	1.0